Abstract.7-(Benzyloxy)-4-chloro-6-methoxyquinazoline (1) was synthesized from methyl 4-hydroxy-3-methoxybenzoate (2) through five steps including substitution, nitration, reduction, cyclization and chlorination.Its structure was confirmed by 1 H NMR and MS spectrum. The total yield of the five steps was 29.2%.
Introduction
Cancer is one of the major diseases that threaten human health. The incidence of cancer is the second only to cardiovascular and cerebrovascular diseases, and it's mortality rate is the highest among all diseases [1] . According to the World Health Organization (WHO) statistics, the death of cancer patients reached 7.6 million. It has been predicted that the world will have 21.4 million new cases by 2030 [2] . Although a series of antitumor drugs and surgeries are available, the slow efficacy of the antitumor drugs and the cancer recurrence are still problems [3] . Therefore, searching for highly efficient and safe chemotherapeutic agents for treating cancer remains desirable.
Quinazoline compounds are one kind of effective EGFR inhibitors [4] , such as Gefitinib(a),Erlotinib(b) and Lapatinib(c),which own the structure of quinazoline. So they are drugs with good anti-tumor activity [5] [6] .The compound 1 is a quinazoline compound. It is an important intermediate in the synthesis of Vandetanib [7] [8] [9] [10] [11] [12] . The structures of those compounds were shown in Fig. 1 .
Fig. 1 Sructures of drugs containing quinoline necleus

Materials and methods
NMR spectra were performed using Bruker 400 MHz spectrometers (Bruker Bioscience, Billerica, MA, USA) with TMS as an internal standard. Mass spectra (MS) were taken in ESI mode
International Conference on Applied Science and Engineering Innovation (ASEI 2015) on Agilent 1100 LC-MS (Agilent, Palo Alto, CA, USA). All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254 (Qindao Haiyang Chemical,China)
Synthesis of compounds
The structures and the synthetic route were shown in Scheme 1. 
Methyl 4-(benzyloxy)-3-methoxybenzoate(3)
BnCl (3.5mL,30mmol), K 2 CO 3 (4.14g,30mmol) and methyl 4-hydroxy-3-methoxybenzoate (5.46g,30mmol) was added to DMF(15mL). Heated to 100 o C and stirred for 7h.After colling to room temperature, the reactant was added to 100ml ice-water mixture slowly. The product was filtered off and dried to afford 7.91g methyl 4-(benzyloxy)-3-methoxybenzoate(3).yield:97%.
Methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate(4)
4-(benzyloxy)-3-methoxybenzoate(3).(2.72g,10mmol) was dissolved in 10mL CHCl 3 .The mixture of HNO 3 (0.67mL,15mmol) and H 2 SO 4 (0.97mL,18.3mmol) then was added dropwise in ice-bath. Heated to room temperature for 6h.Then ice-water was added to the reaction system, pointed to the water. Choroform layer was washed with staturated bicarbonate solution, with water washing to be neutral. Evaporating the solvent and dried to afford 1.1g methyl 4-(benzyloxy)-5-methoxy-2-nitrobenzoate(4).yield:69.4%.ESI-MS m/z: 318.1(M+H) + .
Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate(5)
4-(benzyloxy)-5-methoxy-2-nitrobenzoate(4)(3.17g,10mmol) and Na 2 S(4.68g,60mmol) were dissolved in 8mL CH 3 CH 2 OH, then heated to79 o C and stirred for 1.5h.After cooling to room temperature,added 10mL CH 3 CH 2 OH to the reaction system,filtration,removal of inorganic substances,evaporating the filtrate rotary and dried to afford 2.71g methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate(5).yield:94.4%. ESI-MS m/z:288.3(M+H) + .
7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one(6)
Methyl 2-amino-4-(benzyloxy)-5-methoxybenzoate(5)(0.3g,1mmol) and formamidine acetate(0.2g,1.4mmol) were dissolved in 7mL CH 3 CH 2 OH,heated to 79 o C and stirred for 6h.Then cooling to room temperature, The product was filtered off and dried to afford 0.24g 7-(benzyloxy)-6-methoxyquinazolin-4(3H)-one (6) .yield:85%.
7-(benzyloxy)-4-chloro-6-methoxyquinazoline(1) 5mL POCl 3 was added to 7-(benzyloxy) -6-methoxyquinazolin-4(3H)-one(6) (0.1g,0.4mmol), heated to 106 o C and stirred, when the liquid changed from cloudy to clarify, the reaction was completed. Cooling to room temperature and slowly driping into the ice-water. The product was filtered off and dried to afford 0.096g 7-(benzyloxy) -4-chloro-6 -methoxyquinazoline (1). yield: 80.1%.
Conclusions
In conclusion, the compound 1 is a quinazoline compound. It is an important intermediate in the synthesis of Vandetanib. It was synthesized from methyl 4-hydroxy-3-methoxybenzoate(2) through five steps including substitution, nitration, reduction, cyclization and chlorination. Its structure was confirmed by 1 H NMR and MS spectrum.
